In a report published on Tuesday, Canaccord Genuity analyst Jason R. Mills downgraded Intuitive Surgical ISRG from Buy to Hold and lowered the price target from $527 to $444.
In the report, Canaccord Genuity noted, "However, Q2 results usurped our most bearish scenario; represented ISRG's worst system placement performance (-6% Y/Y) since the height of the financial crisis in Q3/09; and most notably, exhibited a significant deviation from historic growth trends – ISRG had reported system sales growth >15% for 9 consecutive quarters".
Intuitive Surgical closed on Monday at $500.08.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.